Addison Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
2,270
+360
+19% +$365K 0.37% 67
2025
Q4
$2.05M Buy
+1,910
New +$1.83M 0.51% 56

Other funds holding LLY

Addison Capital's LLY Position: Q1 2026 in Review

Addison Capital increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $365K and bringing the position to 2,270 shares worth $2.09M. The position accounts for 0.37% of the portfolio, ranked #67.

Addison Capital first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Addison Capital held 2,270 shares of Eli Lilly worth $2.09M as of Q1 2026.
  • Addison Capital bought 360 Eli Lilly shares in Q1 2026, an estimated $365K.
  • Eli Lilly made up 0.37% of Addison Capital's portfolio in Q1 2026, its #67 holding.
  • Addison Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Addison Capital's 13F filing for Q1 2026, filed 29 Apr 2026.